[Experimental study on rejection of allogeneic donor bone marrow cells in sensitized recipients]
- PMID: 22339907
[Experimental study on rejection of allogeneic donor bone marrow cells in sensitized recipients]
Abstract
Objective: To establish a murine model of sensitization, and investigate the effect and mechanism of sensitization on allogeneic donor bone marrow cells (BMCs).
Methods: Sensitized BALB/c mice were established by transfusions of allogeneic splenocytes. The donor reactive antibodies were detected by binding and complement-dependent cytotoxicity assays. After irradiation, 1 × 10(7) BMCs of C57BL/6 donor mice were injected into non-sensitized or sensitized BALB/c recipient mice. The distribution pattern of donor BMCs in peripheral blood, spleen and bone marrow of recipient mice were analyzed at different time points (2 h, 12 h and 48 h) post transplantation. Hematopoietic recovery post transplantation was assessed, and survival was monitored. Moreover, sera and splenocytes derived from non-sensitized or sensitized recipients were incubated with allogeneic BMCs in vitro, and the cytotoxic indexes were calculated in the immune experiments.
Results: The binding and complement-dependent cytotoxicity assays showed that a high level of donor reactive antibodies was presented in sensitized sera. Compared with the non-sensitized recipients, the homing assay showed significantly decreased distributions of allogeneic donor BMCs in peripheral blood, spleen and femur of sensitized recipients. Non-sensitized recipients survived long term after irradiation, while all the sensitized recipients died within 12-15 days. Fourteen days post transplantation, the white blood cells and BMCs of non-sensitized recipients were (3240 ± 300) × 10(6)/L and (396 ± 27) × 10(6)/femur, respectively; while the white blood cells and BMCs of sensitized recipients were (320 ± 80) × 10(6)/L and (6 ± 2) × 10(6)/femur, respectively; the differences were statistically significant between this two groups (P < 0.05). Seven days post transplantation, the percentage of donor cells in bone marrow of non-sensitized and sensitized recipients was (48.07 ± 4.70)% and (0.77 ± 0.11)%, respectively, and the differences were statistically significant (P < 0.05). Furthermore, the white blood cells and BMCs following transplantation decreased along with time in sensitized recipients. The immune experiments of complement-dependent cytotoxicity reaction, cytotoxic T lymphocytes reaction and antibody-dependent cellular cytotoxicity showed the cytotoxic indexes were higher in sensitized group than the non-sensitized group.
Conclusion: A sensitized model was established by transfusions of allogeneic spleen cells. Allogeneic donor BMCs were rejected in sensitized recipients, and its mechanism might be through immune impairment pathways.
Similar articles
-
Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells.Bone Marrow Transplant. 2007 Oct;40(7):691-8. doi: 10.1038/sj.bmt.1705791. Epub 2007 Jul 30. Bone Marrow Transplant. 2007. PMID: 17660838
-
Application of mesenchymal stromal cells in bone marrow transplantation for sensitized recipients.Acta Haematol. 2012;127(2):105-9. doi: 10.1159/000333554. Epub 2011 Dec 15. Acta Haematol. 2012. PMID: 22178869
-
Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.Transplantation. 2006 Sep 15;82(5):689-98. doi: 10.1097/01.tp.0000235589.66683.0e. Transplantation. 2006. PMID: 16969294
-
Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.Transpl Immunol. 2003 Jul-Sep;11(3-4):307-21. doi: 10.1016/S0966-3274(03)00056-X. Transpl Immunol. 2003. PMID: 12967784 Review.
-
New strategies for allogeneic bone marrow transplantation and organ allografts.Acta Haematol. 1999;101(2):68-77. doi: 10.1159/000040927. Acta Haematol. 1999. PMID: 10202236 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical